AK Medical Holdings Limited
HKEX:1789.HK
5.6 (HKD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,346.377 | 1,093.862 | 1,052.047 | 761.441 | 1,035.386 | 926.705 | 600.562 | 372.7 | 270.777 | 206.164 | 148.278 |
| Cost of Revenue
| 538.184 | 419.376 | 415.612 | 262.252 | 320.854 | 283.454 | 191.681 | 108.91 | 83.466 | 64.108 | 46.933 |
| Gross Profit
| 808.193 | 674.486 | 636.435 | 499.189 | 714.532 | 643.251 | 408.881 | 263.79 | 187.311 | 142.056 | 101.345 |
| Gross Profit Ratio
| 0.6 | 0.617 | 0.605 | 0.656 | 0.69 | 0.694 | 0.681 | 0.708 | 0.692 | 0.689 | 0.683 |
| Reseach & Development Expenses
| 139.206 | 137.126 | 110.865 | 113.069 | 104.974 | 80.527 | 45.595 | 34.963 | 20.39 | 18.878 | 15.539 |
| General & Administrative Expenses
| 143.949 | 133.441 | 118.313 | 105.316 | 83.016 | 92.203 | 74.125 | 56.222 | 50.291 | 32.03 | 19.277 |
| Selling & Marketing Expenses
| 240.911 | 218.806 | 180.107 | 187.347 | 154.101 | 175.334 | 122.877 | 50.397 | 9.522 | 7.722 | 3.25 |
| SG&A
| 384.86 | 352.247 | 298.42 | 292.663 | 237.117 | 267.537 | 197.002 | 106.619 | 59.813 | 39.752 | 22.527 |
| Other Expenses
| -16.654 | -26.37 | -11.193 | -5.979 | -5.333 | -7.491 | -4.943 | -2.68 | 13.738 | 10.469 | 5.488 |
| Operating Expenses
| 507.412 | 463.003 | 398.092 | 399.753 | 336.758 | 340.573 | 237.654 | 138.902 | 93.941 | 69.099 | 43.554 |
| Operating Income
| 300.781 | 211.483 | 219.983 | 99.436 | 368.926 | 315.521 | 171.227 | 124.888 | 93.37 | 72.957 | 57.791 |
| Operating Income Ratio
| 0.223 | 0.193 | 0.209 | 0.131 | 0.356 | 0.34 | 0.285 | 0.335 | 0.345 | 0.354 | 0.39 |
| Total Other Income Expenses Net
| 19.041 | 19.634 | 20.307 | 9.123 | 7.681 | 18.064 | 3.273 | -0.504 | 1.657 | 2.994 | 2.506 |
| Income Before Tax
| 319.822 | 231.117 | 240.29 | 108.559 | 376.607 | 321.402 | 174.5 | 125.384 | 95.027 | 75.951 | 60.297 |
| Income Before Tax Ratio
| 0.238 | 0.211 | 0.228 | 0.143 | 0.364 | 0.347 | 0.291 | 0.336 | 0.351 | 0.368 | 0.407 |
| Income Tax Expense
| 45.896 | 49.013 | 35.518 | 15.94 | 62.6 | 54.41 | 29.564 | 20.008 | 17.701 | 11.044 | 8.576 |
| Net Income
| 273.926 | 182.104 | 204.772 | 92.619 | 314.007 | 266.992 | 144.936 | 105.376 | 77.326 | 64.907 | 51.721 |
| Net Income Ratio
| 0.203 | 0.166 | 0.195 | 0.122 | 0.303 | 0.288 | 0.241 | 0.283 | 0.286 | 0.315 | 0.349 |
| EPS
| 0.24 | 0.16 | 0.18 | 0.08 | 0.28 | 0.26 | 0.14 | 0.14 | 0.077 | 0.065 | 0.052 |
| EPS Diluted
| 0.24 | 0.16 | 0.18 | 0.08 | 0.28 | 0.25 | 0.14 | 0.14 | 0.077 | 0.065 | 0.052 |
| EBITDA
| 371.661 | 323.343 | 322.865 | 184.326 | 438.411 | 341.38 | 195.258 | 137.129 | 101.694 | 77.895 | 62.239 |
| EBITDA Ratio
| 0.276 | 0.296 | 0.307 | 0.242 | 0.423 | 0.368 | 0.325 | 0.368 | 0.376 | 0.378 | 0.42 |